VivaVision Biotech (Zhejiang) Co., Ltd.

维眸生物科技(浙江)股份有限公司

Develops small-molecule ophthalmic drugs targeting ocular surface and posterior segment diseases, with R&D centers and subsidiaries in China and overseas, and plans to commercialize product candidates in domestic and international markets.

Filings

The documents are on HKEXnews; we link to the originals.

Matters the filing discloses

From the company’s latest filing; open a kind of matter to see how other companies disclosed it.

• Leased property
• Social insurance & housing fund
• Supplier concentration
• Reliance on platforms, partners or licences
• Outsourced production (OEM / contract manufacturing)
• Cash burn and runway
• Related-party transactions and balances
• Chapter 18A biotech